Company Filing History:
Years Active: 2019
Title: Thomas Cailly: Innovator in RNA Functionalization
Introduction
Thomas Cailly is a notable inventor based in Caen, France. He has made significant contributions to the field of biochemistry, particularly in the functionalization of ribonucleic acid (RNA) molecules. His innovative work has led to the development of methods that enhance the functionality of biological molecules.
Latest Patents
Cailly holds a patent for "Methods of functionalization and reagents used in such methods using an aza-isatoic anhydride or a derivative thereof, biological molecules thus treated and kits." This invention relates to a method of functionalizing RNA molecules contained in a liquid sample. The process involves providing a binding molecule consisting of an aza-isatoic anhydride, a group of interest, and a linkage that connects the binding molecule to the group of interest. The method includes reacting the anhydride function with hydroxyl groups on the RNA nucleotides, resulting in an aza-anthranilate that links the RNA to the group of interest.
Career Highlights
Thomas Cailly is currently employed at bioMérieux, Inc., a company renowned for its expertise in diagnostics and biotechnology. His work at bioMérieux has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in the field.
Collaborations
Cailly has collaborated with notable colleagues, including Frédéric Fabis and Ali Laayoun. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Thomas Cailly's contributions to RNA functionalization exemplify the impact of innovative thinking in biochemistry. His patent and work at bioMérieux highlight the importance of advancements in the field, paving the way for future developments.